hMG increases the yield of mature oocytes and excellent-quality embryos in patients with a previous cycle having a high incidence of oocyte immaturity

Fertility and Sterility

Volumn 92, Issue 3, 2009, Pages 946-949

  Huddleston, Heather G ^a   Jackson, Katharine V ^b   Doyle, Joseph O ^b   Racowsky, Catherine ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE;

ADULT; ARTICLE; EMBRYO; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INCIDENCE; INDIVIDUALIZATION; OOCYTE MATURATION; PATIENT SELECTION; PRIORITY JOURNAL; PRODUCT RECOVERY;

ADULT; COHORT STUDIES; DRUG THERAPY, COMBINATION; EMBRYO, MAMMALIAN; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE; HORMONES; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; MENOTROPINS; MENSTRUAL CYCLE; OOCYTES; OVULATION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 69049099935     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.039     Document Type: Article

References (21)

1. Hillier S.G. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 179 (2001) 39-46
2. Fischer R. Understanding the role of LH: myths and facts. Reprod Biomed Online 15 (2007) 468-477
3. Westergaard L.G., Laursen S.B., and Andersen C.Y. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 15 (2000) 1003-1008
4. Esposito M.A., T. Barnhart K., Coutifaris P., and Patrizio C. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil Steril 75 (2001) 519-524
5. Balasch J., Penarrubia J., Fabregues F., Vidal E., Casamitjana R., Mana D., et al. Ovarian responses to recombinant FSH or hMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction. Reprod Biomed Online 7 (2003) 35-42
6. Fabregues F., Creus M., Penarrubia J., Manau D., Vanrell J.A., Balasc J., et al. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age. Fertil Steril 85 (2006) 925-931
7. N. Andersen A., Devroey P., and Arce J.C. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod 21 (2006) 3217-3227
8. Marrs R., Meldrum D., Muasher S., Schoolcraft W., Werlin L., Kell E., et al. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online 8 (2004) 175-182
9. Nyboeandersen A., Humaidan P., Fried G., Hausken J., Antila L., Bangsboll S., et al. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. Hum Reprod 23 (2008) 427-434
10. Chung K., Krey L., Katz J., and Noyes N. Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists. Fertil Steril 84 (2005) 313-318
11. Barrenetxea G., Girregoikoa J.A., Jimenez M.R., de Larruzea A.L., Ganzabal T., Carbonero K., et al. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 89 (2008) 546-553
12. Balasch J., Burzaco I., Casamitjana R., Civico, and Ballesca J.L. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum Reprod Suppl 10 (1995) 1678-1683
13. Tesarik J., and Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod 17 (2002) 3129-3137
14. Hull M.G., Armatage R.J., and McDermott A. Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization. Fertil Steril 62 (1994) 997-1003
15. De Placido G., Alviggi C., Perino A., Strina I., Lisi F., Fasolin F., et al. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 20 (2005) 390-396
16. Lisi F., Rinaldi L., Fishel S., Lisi R., Pepe G.P., Picconer M.G., et al. Use of recombinant LH in a group of unselected IVF patients. Reprod Biomed Online 5 (2002) 104-108
17. Cedrin-Durnerin I., Grange-Dujardin D., Laffy A., Parneix I., Massin N., Gale J., et al. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum Reprod 19 (2004) 1979-1984
18. Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 77 (2002) 1170-1177
19. Humaidan P., Bungum L., Bungum M., and Andersen C.Y. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 17 (2002) 2016-2021
20. Balasch J., Creus M., Fabregues F., Civico S., Carmona F., Puert B., et al. Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod 16 (2001) 1636-1643
21. Penarrubia J., Fabregues F., Creus M., Manau D., Casamitjana R., Guimer M., et al. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. Hum Reprod 18 (2003) 2689-2697